Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with Fujifilm as the ...

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said it has resubmitted its biologics license application for MOLBREEVI to the U.S ...

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Learn how to rapidly identify, manage, and prevent drowning injuries using updated evidence-based approaches from prehospital care to ICU management.

Following the recent approval of nerandomilast tablets for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, the FDA has approved the medication for progressive pulmonary fibrosis as ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Using 21 st century diagnostics to overcome barriers for lung function testing in primary care: it is time to consider oscillometry Obstructive airways diseases, including asthma and COPD as the most ...

You will be redirected to our submission process. Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of alveoli, and growth of blood ...

If you have trouble breathing, your doctor may recommend a few tests to figure out what’s causing it. Some measure how much air you breathe in or out or how much oxygen is going from your lungs to the ...